| P50 | author | Piotr Pruszczyk | Q21020316 |
| | Justyna Domienik-Karłowicz | Q89132959 |
| | Zuzanna Rymarczyk | Q114342128 |
| | Olga Dzikowska-Diduch | Q114342140 |
| | Wojciech Lisik | Q57202189 |
| | Urszula Demkow | Q87115735 |
| | Andrzej Chmura | Q29830271 |
| P2860 | cites work | Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients. | Q51374912 |
| | Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. | Q51455949 |
| | Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease. | Q51461924 |
| | Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. | Q51498412 |
| | Circulating serum adiponectin concentrations do not differ between obese and non-obese caucasians and are unrelated to insulin sensitivity. | Q51770263 |
| | Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. | Q54790389 |
| | Interdisciplinary European Guidelines for Surgery for Severe (Morbid) Obesity | Q60209702 |
| | Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity | Q67946861 |
| | Adiponectin levels do not change with moderate dietary induced weight loss and exercise in obese postmenopausal women | Q73807103 |
| | The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein | Q82544435 |
| | Elevated soluble CD40 ligand in diabetic patients with painless myocardial infarction | Q83846507 |
| | Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages | Q24290861 |
| | Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention | Q28168588 |
| | Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome | Q33984448 |
| | Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone | Q33984832 |
| | The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people | Q34020389 |
| | Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 |
| | Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 |
| | Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism | Q35641736 |
| | New aspects of vascular remodelling: the involvement of all vascular cell types. | Q36127987 |
| | Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates | Q36305029 |
| | Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. | Q36312096 |
| | Do metalloproteinases destabilize vulnerable atherosclerotic plaques? | Q36589031 |
| | Non-conventional markers of atherosclerosis before and after gastric banding surgery | Q39986083 |
| | Effect of pronounced weight loss on the nontraditional cardiovascular risk marker matrix metalloproteinase-9 in middle-aged morbidly obese women. | Q40449361 |
| | Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation | Q40783644 |
| | Increased concentrations of soluble vascular cell adhesion molecule-1 and soluble CD40L in subjects with metabolic syndrome | Q42743516 |
| | Enhanced levels of soluble CD40 ligand and C-reactive protein in a total of 312 patients with metabolic syndrome | Q43223845 |
| | Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity | Q44526989 |
| | Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women | Q44795851 |
| | Matrix metalloproteinase-2 and -9 levels in obese patients. | Q45901657 |
| | Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. | Q46028453 |
| | Effect of weight loss on proinflammatory state of mononuclear cells in obese women | Q46689839 |
| | Weight gain as a risk factor for clinical diabetes mellitus in women | Q47356176 |
| | Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. | Q47369917 |
| | Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial. | Q47385120 |
| | Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans | Q47733437 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P921 | main subject | bariatric surgery | Q357503 |
| P304 | page(s) | 486-493 | |
| P577 | publication date | 2015-03-01 | |
| P1433 | published in | Obesity Surgery | Q15762541 |
| P1476 | title | Emerging markers of atherosclerosis before and after bariatric surgery | |
| P478 | volume | 25 | |